In chronic urticaria patients Which drug is better between tab bilastine 20 mg and tab levocetirizine 10 mg
Not Applicable
- Conditions
- Health Condition 1: L509- Urticaria, unspecified
- Registration Number
- CTRI/2022/12/047982
- Lead Sponsor
- Dr Jaydev Singh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of acute & chronic urticaria aged between 18-75 years.
Patients who are willing to give written informed consent
Patients with minimum UAS of 5 or greater than it
Exclusion Criteria
Patients with : Urticarial vasculitis
Senile prutitus
Drug induced urticaria
Herediatary angioedema will be excluded
Patient taken antihistaminic in last 4 weeks
Patient taken corticosteroid in last 4 weeks
Patient having known hypersensitivity to the drug
Patients on immunosuppressive therapy ( cyclosporine, methotrexate, azathioprine)
Pregnant and lactating females
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary : <br/ ><br> To compare UAS (Urticaria Actrivity Score) between both groups at end of 12 weeks. <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: AT END OF 4TH, 8TH, 12TH WEEK <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1. To observe % of non responders <br/ ><br>2.To observe % of dose increased <br/ ><br>3. To observe number of patients in whom corticosteroid was given <br/ ><br>4. To observe any adverse drug effects, if occurred. <br/ ><br>5.To compare the safety of Tab Bilastine 20mg Vs Tab Levocetirizine 10mg <br/ ><br>Timepoint: AT END OF 4TH, 8TH, 12TH WEEK <br/ ><br>